Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1beta secretion and insulin resistance despite obesity
Myth #5: GLP-1 agonists are unsafe with numerous side effects Concerns about the safety of GLP-1 agonists and their potential side effects are common, leading some people to avoid these treatments altogether
Caffeine is known to relax the lower esophageal sphincter (LES), the muscle that acts as a valve between the esophagus and the stomach
Contrarily, in another metaanalysis, no gender differences were noted in terms of MACE reduction in DKD patients treated with either SGLT2i or GLP-1RA (Diallo et al., 2022)
The symposium will provide a broad understanding, from amylin biology to potential translation to clinical care via the phase 3 trials. REIMAGINE 2 compared CagriSema versus its individual components, cagrilintide and two semaglutide doses, and placebo in a population living with type 2 diabetes on metformin with or without a sodium-glucose cotransporter-2 (SGLT2) inhibitor
Joshi SS, et al